
XTL Biopharmaceuticals Ltd. XTLB
$ 0.76
-0.61%
Annual report 2024
added 02-21-2026
XTL Biopharmaceuticals Ltd. EBITDA per Share 2011-2026 | XTLB
Annual EBITDA per Share XTL Biopharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -0.18 | -0.16 | -0.15 | -0.27 | -0.624 | -0.755 | -0.871 | -0.986 | -1.08 | -0.566 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.15 | -1.08 | -0.564 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
0.45 | $ 20.32 | -1.86 % | $ 2.56 B | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 0.82 | -2.7 % | $ 4.47 M | ||
|
Axsome Therapeutics
AXSM
|
-3.34 | $ 165.39 | -0.6 % | $ 8.23 B | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 3.65 | -4.58 % | $ 1.09 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 8.35 | -4.41 % | $ 1.4 B | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Corvus Pharmaceuticals
CRVS
|
-0.48 | $ 17.24 | -3.63 % | $ 828 M | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Capricor Therapeutics
CAPR
|
-0.86 | $ 25.62 | -4.62 % | $ 686 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
-0.73 | $ 0.99 | -2.59 % | $ 72.7 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
-408 | $ 3.18 | -4.94 % | $ 1.14 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
-8.05 | $ 28.47 | -2.5 % | $ 1.65 B | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Завод ДИОД
DIOD
|
2.37 | - | - | - | ||
|
Фармсинтез
LIFE
|
-0.23 | - | - | - | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
-2.92 | $ 3.64 | -4.21 % | $ 116 M | ||
|
Alector
ALEC
|
-1.46 | $ 2.13 | -3.39 % | $ 219 M | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-3.63 | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
-1.45 | $ 4.15 | -0.24 % | $ 295 M | ||
|
Teligent, Inc.
TLGT
|
8.97 | - | -13.85 % | $ 16.1 M | ||
|
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | ||
|
Viela Bio, Inc.
VIE
|
1.54 | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.11 | $ 24.06 | 0.75 % | $ 2.94 B | ||
|
Amarin Corporation plc
AMRN
|
-0.11 | $ 13.95 | 0.14 % | $ 5.79 B | ||
|
AbbVie
ABBV
|
8.95 | $ 231.93 | -0.98 % | $ 410 B | ||
|
Blueprint Medicines Corporation
BPMC
|
0.26 | - | - | $ 8.14 B | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M |